365 related articles for article (PubMed ID: 29605575)
1. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
2. Endocrine, prostatic vascular, and proapoptotic changes in dogs with benign prostatic hyperplasia treated medically or surgically.
Lima CB; Angrimani DSR; Flores RB; Vannucchi CI
Domest Anim Endocrinol; 2021 Apr; 75():106601. PubMed ID: 33333452
[TBL] [Abstract][Full Text] [Related]
3. Prostatic hyperplasia: Vascularization, hemodynamic and hormonal analysis of dogs treated with finasteride or orchiectomy.
Angrimani DSR; Francischini MCP; Brito MM; Vannucchi CI
PLoS One; 2020; 15(6):e0234714. PubMed ID: 32584842
[TBL] [Abstract][Full Text] [Related]
4. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
[TBL] [Abstract][Full Text] [Related]
5. Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.
Angrimani DSR; Brito MM; Rui BR; Nichi M; Vannucchi CI
Sci Rep; 2020 Sep; 10(1):14834. PubMed ID: 32908208
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
Liu Q; Zhu Y; Liu J; Qi J; Kang J
Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of the GnRH agonist (deslorelin) in dogs affected by benign prostatic hyperplasia and evaluation of prostatic blood flow by Doppler ultrasound.
Polisca A; Orlandi R; Troisi A; Brecchia G; Zerani M; Boiti C; Zelli R
Reprod Domest Anim; 2013 Aug; 48(4):673-80. PubMed ID: 23320475
[TBL] [Abstract][Full Text] [Related]
8. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Johnston SD; Kustritz MV; Johnston GR; Sarkar DK; Memon MA
J Am Vet Med Assoc; 2001 Apr; 218(8):1275-80. PubMed ID: 11330612
[TBL] [Abstract][Full Text] [Related]
9. Power and pulsed Doppler evaluation of prostatic artery blood flow in normal and benign prostatic hyperplasia-affected dogs.
Zelli R; Orlandi R; Troisi A; Cardinali L; Polisca A
Reprod Domest Anim; 2013 Oct; 48(5):768-73. PubMed ID: 23505997
[TBL] [Abstract][Full Text] [Related]
10. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
11. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia.
Hochberg DA; Basillote JB; Armenakas NA; Vasovic L; Shevchuk M; Pareek G; Fracchia JA
J Urol; 2002 Apr; 167(4):1731-3. PubMed ID: 11912398
[TBL] [Abstract][Full Text] [Related]
12. Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs.
Iguer-Ouada M; Verstegen JP
J Reprod Fertil Suppl; 1997; 51():139-49. PubMed ID: 9404280
[TBL] [Abstract][Full Text] [Related]
13. Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
Cyrus A; Kabir A; Goodarzi D; Talaei A; Moradi A; Rafiee M; Moghimi M; Shahbazi E; Farmani E
Korean J Urol; 2014 Dec; 55(12):814-20. PubMed ID: 25512816
[TBL] [Abstract][Full Text] [Related]
14. Finasteride-induced prostatic involution by apoptosis in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Sirinarumitr T; Johnston SD; Sarkar DK; Kustritz MV
Am J Vet Res; 2002 Apr; 63(4):495-8. PubMed ID: 11939309
[TBL] [Abstract][Full Text] [Related]
15. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
[TBL] [Abstract][Full Text] [Related]
17. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
Li R; Jia DY; Li Z; Xu DR; Luo SY
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
[TBL] [Abstract][Full Text] [Related]
19. Intra-prostatic injection of botulinum toxin type A in treatment of dogs with spontaneous benign prostatic hyperplasia.
Mostachio GQ; Apparício M; Motheo TF; Alves AE; Vicente WR
Anim Reprod Sci; 2012 Aug; 133(3-4):224-8. PubMed ID: 22819377
[TBL] [Abstract][Full Text] [Related]
20. Frozen-Thawed Sperm Analysis of Benign Prostatic Hyperplasia Dogs Treated With Finasteride.
Flores RB; Angrimani DSR; Brito MM; de Almeida LL; Lopes JVM; Losano JDA; Vannucchi CI
Front Vet Sci; 2022; 9():901943. PubMed ID: 35847633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
